Hyderabad, (Telangana) [India] 4 August 2026: The Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID) is pleased to announce that the GANSID Congress 2026 will be held from October 23–25, 2026, at the HICC, Novotel, Hyderabad in collaboration with GANSID, USA, and hosted by the Thalassemia and Sickle Cell Society (TSCS), Hyderabad, serving as local partner.
The Congress will bring together hundreds of renowned national and international speakers, leading clinicians, researchers, laboratory and translational scientists, patient organizations, industry partners, policymakers, and global health agencies to share the latest advances, research, and best practices in the field of inherited blood disorders.
This year’s theme, “From Innovation to Implementation: Bridging Science and Access in Inherited Blood Disorders,” reflects the Congress’s commitment to translating scientific progress into real-world impact for patients and communities worldwide.
Spanning three days, the program includes plenary sessions, abstract and poster presentations, industry symposia, early-career and mid-late-career sessions, patient engagement sessions, a presentation theatre, and dedicated networking opportunities, including an opening ceremony and a networking reception.
Speaking about the event Dr. Chandrakanth Agarwal, President, TSCS said, “Hyderabad hosting such a prestigious event is a remarkable opportunity for the community. We warmly invite all participants to attend this prestigious conference, attend the scientific sessions, interact with experts, and benefit from this exceptional learning and networking opportunity.”
Participants can look forward to scientific sessions, expert interactions, and networking opportunities with leading voices from around the world in the space of sickle cell disease and related disorders.
Delegates can register via https://tinyurl.com/GANSIDCongress2026
